Nature:哺乳动物宿主CD8 T细胞数量的适应性变化 - 生物研究-生物谷

反复暴露于病原体及以杀死病原体为使命的记忆性CD8+T-细胞的生成,被认为会导致事先存在的记忆性T-细胞存量的消耗,以保持记忆腔的总体大小不变。但用小鼠进行的新的研究工作表明,记忆性CD8+T-细胞腔的大小在免疫之后会增加,而且新的记忆性CD8+ T-细胞的生成并不会显著减少事先存在的记忆性CD8+T-细胞的数量。关于哺乳动物宿主CD8+T-细胞数量能根据免疫经验发生适应性变化的发现,对于疫苗的生产可能具有重要意义,因为我们也许有可能大量引入特异性CD8+T-细胞,而不会影响以前就有的、针对其他感染的免疫能力。(生物谷Bioon.com)

生物谷推荐原始出处:

Nature 457, 196-199 (8 January 2009) | doi:10.1038/nature07486

Memory CD8 T-cell compartment grows in size with immunological experience

Vaiva Vezys1,2,4, Andrew Yates3,4, Kerry A. Casey1, Gibson Lanier2, Rafi Ahmed2, Rustom Antia3 & David Masopust1,2

1 Department of Microbiology and Center for Immunology, University of Minnesota, Minneapolis, Minnesota 55455, USA

2 Emory Vaccine Center, Emory University School of Medicine, and,

3 Department of Biology, Emory University, Atlanta, Georgia 30322, USA

4 These authors contributed equally to this work.

Memory CD8 T cells, generated by natural pathogen exposure orintentional vaccination, protect the host against specific viralinfections1. It has long been proposed that the number of memory CD8 Tcells in the host is inflexible, and that individual cells areconstantly competing for limited space2, 3. Consequently, vaccines thatintroduce over-abundant quantities of memory CD8 T cells specific for anagent of interest could have catastrophic consequences for the host bydisplacing memory CD8 T cells specific for all previous infections4, 5,6. To test this paradigm, we developed a vaccination regimen in micethat introduced as many new long-lived memory CD8 T cells specific for asingle vaccine antigen as there were memory CD8 T cells in the hostbefore vaccination. Here we show that, in contrast to expectations, thesize of the memory CD8 T-cell compartment doubled to accommodate thesenew cells, a change due solely to the addition of effector memory CD8 Tcells. This increase did not affect the number of CD4 T cells, B cellsor naive CD8 T cells, and pre-existing memory CD8 T cells specific for apreviously encountered infection were largely preserved. Thus, thenumber of effector memory CD8 T cells in the mammalian host adaptsaccording to immunological experience. Developing vaccines thatabundantly introduce new memory CD8 T cells should not necessarilyablate pre-existing immunity to other infections.

反复暴露于病原体及以杀死病原体为使命的记忆性CD8+T-细胞的生成,被认为会导致事先存在的记忆性T-细胞存量的消耗,以保持记忆腔的总体大小不变。但用小鼠进行的新的研究工作表明,记忆性CD8+T-细胞腔的大小在免疫之后会增加,而且新的记忆性CD8+ T-细胞的生成并不会显著减少事先存在的记忆性CD8+T-细胞的数量。关于哺乳动物宿主CD8+T-细胞数量能根据免疫经验发生适应性变化的发现,对于疫苗的生产可能具有重要意义,因为我们也许有可能大量引入特异性CD8+T-细胞,而不会影响以前就有的、针对其他感染的免疫能力。(生物谷Bioon.com)

生物谷推荐原始出处:

Nature 457, 196-199 (8 January 2009) | doi:10.1038/nature07486

Memory CD8 T-cell compartment grows in size with immunological experience

Vaiva Vezys1,2,4, Andrew Yates3,4, Kerry A. Casey1, Gibson Lanier2, Rafi Ahmed2, Rustom Antia3 & David Masopust1,2

1 Department of Microbiology and Center for Immunology, University of Minnesota, Minneapolis, Minnesota 55455, USA

2 Emory Vaccine Center, Emory University School of Medicine, and,

3 Department of Biology, Emory University, Atlanta, Georgia 30322, USA

4 These authors contributed equally to this work.

Memory CD8 T cells, generated by natural pathogen exposure orintentional vaccination, protect the host against specific viralinfections1. It has long been proposed that the number of memory CD8 Tcells in the host is inflexible, and that individual cells areconstantly competing for limited space2, 3. Consequently, vaccines thatintroduce over-abundant quantities of memory CD8 T cells specific for anagent of interest could have catastrophic consequences for the host bydisplacing memory CD8 T cells specific for all previous infections4, 5,6. To test this paradigm, we developed a vaccination regimen in micethat introduced as many new long-lived memory CD8 T cells specific for asingle vaccine antigen as there were memory CD8 T cells in the hostbefore vaccination. Here we show that, in contrast to expectations, thesize of the memory CD8 T-cell compartment doubled to accommodate thesenew cells, a change due solely to the addition of effector memory CD8 Tcells. This increase did not affect the number of CD4 T cells, B cellsor naive CD8 T cells, and pre-existing memory CD8 T cells specific for apreviously encountered infection were largely preserved. Thus, thenumber of effector memory CD8 T cells in the mammalian host adaptsaccording to immunological experience. Developing vaccines thatabundantly introduce new memory CD8 T cells should not necessarilyablate pre-existing immunity to other infections.


相关内容

  • 肠道微生物与人体健康相关研究进展一览
  • 本期为大家带来的是肠道微生物与机体健康之间的关系的研究进展盘点,希望读者朋友们能够喜欢. 1. Hepatology:药物伤肝?可能跟肠道菌群有关系 DOI: 10.1002/hep.29327 药物会在肝脏被各种酶分子分解变成代谢物随后通过排泄途径以粪便和尿液的形式排除,除此之外药物还会在肠道细菌 ...

  • 1饲用微生态制剂概述
  • 饲用微生态制剂概述 微生态制剂是指利用现代生物工程技术将已知的有益微生物进行培养.发酵.后处理等工艺制成的微生物制剂.微生态制剂包括活菌制剂和微生物培养物,分为益生菌.益生元和合生元三类. 1.益生菌(Probiotics),也称活菌制剂,即能够促进肠内菌群生态平衡,对宿主起有益作用的活菌制剂. 2 ...

  • Nature:PD-1抗体为何对有些患者无效?肿瘤大小在"作祟"!
  • 生物探索编者按 扩大癌症免疫疗法的获益人群是很多科学家团队正在努力攻克的难题.解决这一问题的前提是,弄清楚为何包括PD-1抗体在内的这类疗法不能对一些患者"奏效".本周发表在<自然>杂志上的一项新成果发现,这种"不奏效"与患者治疗前的肿瘤大小有关. ...

  • 生物前沿知识汇总
  • 生物前沿知识汇总 1. Nature :新型转基因水稻既高产又环保(2015.08.01) 水稻是全球超过半数人口的主要能量来源,对于人类的粮食安全有着举足轻重的影响.然而,水稻的生长过程每年会释放超过一亿吨甲烷气体,贡献了全球17%的甲烷(温室气体)的释放量.来自中国福建农科院.中国湖南农业大学. ...

  • 自体细胞免疫治疗
  • [简介] 自体细胞免疫疗法也称为生物免疫疗法中的细胞治疗方法,主要包括三种免疫细胞的疗法--DC .CIK .DCCIK .具体方法是:通过提取患者体内不成熟的免疫细胞(采血),在实验室中进行活化培养使其具有高效识别和细胞的能力后,再回输患者体内.患者只需配合做采血与回输血两个步骤,无需住院. 疗法 ...

  • 医学免疫学概念整理
  • 医学免疫学 免疫系统包括免疫器官.免疫细胞.免疫分子 免疫器官:中枢(胸腺.骨髓.法氏囊)+外周(脾脏.淋巴结.粘膜/皮肤相关淋巴组织) 免疫分子:膜型分子+分泌型分子(免疫球蛋白/抗体/抗毒素.补体.细胞因子) 免疫:识别和清除外来入侵的抗原.功能:防御.监视.自身稳定. 免疫应答包括固有免疫.适 ...

  • 医学免疫学重点总结
  • 医学免疫学重点总结 医学免疫学重点总结 第一讲 绪论 1.概念: 1).免疫(immunity): 即免除疫病和抵抗疾病的发生.是机体识别"自己", 排除"异己(非己)"过程中所产生的生物学效应的总和,正常情况下是维持内环境稳定的一种生理性防御功能. 2.免疫 ...

  • 免疫学问答题
  • 免疫学问答题 1.试比较T细胞表位和B细胞表位的主要差异. 答:1)定义:指抗原分子中决定抗原特异性的特殊化学功能基团,是TCR/BCR及抗体特异结合的基本单位,其性质.数目.空间构型决定了抗原的特异性. 2)抗原的结合价:能和抗体分子结合的功能性抗原决定簇的数目. 表位受体 表位性质 表位大小 表 ...

  • 急性移植物抗宿主病的诊疗进展
  • 急性移植物抗宿主病的诊疗进展 白血病.淋巴瘤 2014-05-31 发表评论 分享 文章作者:侯慧明 刘林 急性移植物抗宿主病(aGVHD)是发生在异基因造血干细胞移植(allo-HSCT)后的一种特异的免疫现象,是移植物组织中的免疫活性细胞与组织抗原不相容的受者组织之间的反应. 即便是人类白细胞抗 ...